1. Home
  2. RYOJ vs LIXT Comparison

RYOJ vs LIXT Comparison

Compare RYOJ & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYOJ
  • LIXT
  • Stock Information
  • Founded
  • RYOJ 2015
  • LIXT 2005
  • Country
  • RYOJ Japan
  • LIXT United States
  • Employees
  • RYOJ N/A
  • LIXT N/A
  • Industry
  • RYOJ Professional Services
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • RYOJ Consumer Discretionary
  • LIXT Health Care
  • Exchange
  • RYOJ Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • RYOJ 24.2M
  • LIXT 20.5M
  • IPO Year
  • RYOJ 2025
  • LIXT N/A
  • Fundamental
  • Price
  • RYOJ $5.41
  • LIXT $4.36
  • Analyst Decision
  • RYOJ
  • LIXT
  • Analyst Count
  • RYOJ 0
  • LIXT 0
  • Target Price
  • RYOJ N/A
  • LIXT N/A
  • AVG Volume (30 Days)
  • RYOJ 3.5M
  • LIXT 135.0K
  • Earning Date
  • RYOJ 11-20-2025
  • LIXT 11-11-2025
  • Dividend Yield
  • RYOJ N/A
  • LIXT N/A
  • EPS Growth
  • RYOJ 72.91
  • LIXT N/A
  • EPS
  • RYOJ 0.13
  • LIXT N/A
  • Revenue
  • RYOJ $11,576,848.00
  • LIXT N/A
  • Revenue This Year
  • RYOJ N/A
  • LIXT N/A
  • Revenue Next Year
  • RYOJ N/A
  • LIXT N/A
  • P/E Ratio
  • RYOJ $40.15
  • LIXT N/A
  • Revenue Growth
  • RYOJ 5.60
  • LIXT N/A
  • 52 Week Low
  • RYOJ $1.81
  • LIXT $0.64
  • 52 Week High
  • RYOJ $11.43
  • LIXT $6.26
  • Technical
  • Relative Strength Index (RSI)
  • RYOJ N/A
  • LIXT 42.91
  • Support Level
  • RYOJ N/A
  • LIXT $4.18
  • Resistance Level
  • RYOJ N/A
  • LIXT $4.56
  • Average True Range (ATR)
  • RYOJ 0.00
  • LIXT 0.40
  • MACD
  • RYOJ 0.00
  • LIXT -0.07
  • Stochastic Oscillator
  • RYOJ 0.00
  • LIXT 31.99

About RYOJ rYojbaba Co. Ltd. Common Shares

rYojbaba Co Ltd is engaged in improving and restoring physical and mental health diminished by work-related stress through consulting and health services. The company provides consulting services to labor unions and companies wishing to build constructive relationships with labor unions and health services to osteopathic clinics and osteopathic beauty salons to alleviate physical ailments created by work-related stress.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: